Press release Archives - Inceptua Group

Inceptua and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US

NEWTOWN, PA., and LUXEMBOURG, Dec 6, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with…

Inceptua GroupDecember 6, 2019

Press release

Inceptua appoints new President North America

To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January, 2020. Paul will take on the…

Inceptua GroupDecember 5, 2019

Press release

Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials

BERLIN / MUNICH – 25 November 2019 – The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs…

Inceptua GroupNovember 25, 2019

Press release

Inceptua appoints new CEO

LUXEMBOURG – 11 December 2019 – Inceptua announced today that Stefan Fraenkel has been appointed CEO effective 1 January 2020. Alan Raffensperger is appointed Executive Vice-Chairman of the Inceptua Group.…

Inceptua GroupNovember 11, 2019

Press release

Head of Global Patient Access joins Inceptua

“Clive joining the team to focus on patient access strengthens our commercialization capabilities, offering even greater support to our partner companies as they try to reach patients in need,” says…

Inceptua GroupNovember 9, 2018

Press release

New Chief Medical Officer joins Inceptua

LUXEMBOURG – 10 October 2018 Inceptua Group today announces that Maria Eklind-Cervenka joins as new Chief Medical Officer (CMO). “With Maria joining we are increasing our Medical Leadership, continuing to…

Inceptua GroupOctober 10, 2018

Press release

Strong industry profiles join Inceptua

Key appointments strengthen full lifecycle support for pharma LUXEMBOURG – 5 September 2018 – Inceptua Group (previously Multipharma) today announces the strengthening of its Commercial, Strategy, and Supply Chain teams…

Inceptua GroupSeptember 5, 2018

Press release

Creation of Inceptua Clinical Trial Services marks new era for the company

LUXEMBOURG – 23 APRIL 2018 – Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of…

Inceptua GroupApril 23, 2018

Press release

Industry experts set to transform evolving pre-approval & unlicensed medicines sector with launch of Inceptua Medicines Access

LUXEMBOURG – 1 JUNE 2017 - Multipharma Group today announces the launch of Inceptua Medicines Access, a new speciality business unit that is offering a transformational approach to providing access…

Inceptua GroupJune 1, 2017